RxDoctor Payments Data

Saqib Hasan, MD

Orthopaedic Surgery of the Spine · Oakland, CANPI 1275894214

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Joimax, Inc. at 31.5% of the total. 2025 is the largest year on record at $208,735, more than ten times the $8,901 reported in 2019.

$717,613in general payments, 2019–2025

Across 416 payments — averaging $1725.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Joimax, Inc.$226K
  • Arthrex$214K
  • L&k Biomed CO. , LTD.$74K
  • Centinel Spine, LLC$63K
  • Spineology Inc.$46K
  • Precision Spine, Inc.$31K
  • plus $63K from 31 others

What the payments were for

  • Royalty or licence$23,3473%
  • Consulting fees$317,25344%
  • Speaking & faculty fees$171,74624%
  • Travel & lodging$190,60227%
  • Food & beverage$14,2472%
  • Entertainment$4180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$717,613 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$328,559
Medicare patients
347
Services billed
1,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib31$2,182
Diclofenac Sodium63$954
Gabapentin49$778
Cyclobenzaprine Hcl20$297
Meloxicam87$158
Naproxen21$121
Methylprednisolone11$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Oakland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →